Expanding Access to Twice-Yearly HIV Prevention in Eswatini
|
In December 2025, Eswatini became one of the first African
countries to offer the medication as an alternative to daily HIV-prevention
pills. The ... |
NICE rejects long-acting HIV prevention treatment for NHS use
Lenacapavir, a twice-yearly injection to reduce the risk of HIV infection, should not be routinely available as preventative treatment. View article...